The Angioplasty Balloon Market size was estimated USD 3.05 billion in 2023 and will hit USD 4.18 billion by 2031 growing at a CAGR of 4.01% by 2024-2031.
Due to the less invasive nature of angioplasty as well as technical developments, this rise is being attributed to the technique. Stroke, myocardial infarction, and/or cardiovascular mortality can result from peripheral and coronary artery disorders, which are frequent indicators of atherosclerosis. In the upcoming years, rising rates of these disorders are projected to spur market expansion. For instance, the WHO estimates that in 2021, there will be around 20 million deaths worldwide due to cardiovascular diseases (CVDs). The target demographic base is also anticipated to grow globally, fueling market growth. Additionally, throughout the anticipated period, advancements in imaging technology and the introduction of cutting-edge products are anticipated to fuel market expansion. As the prevalence of artery disease increases, angioplasty balloons have become the go-to treatment for those with coronary and peripheral artery diseases. Coronary artery disease is a fatal disorder that results in cardiac arrest when the heart isn't getting enough blood. A small balloon-tipped catheter is inserted into a blood vessel during an angioplasty treatment, and the catheter is inflated at the site of the blockage to guarantee that the constricting arteries remain open. Additionally, angioplasty balloons are more successful than conventional angioplasty methods, which is predicted to promote market growth.
Get More Information on Angioplasty Balloon Market - Request Sample Report
Furthermore, the incidence of heart illnesses is rising alarmingly, calling for precise, highly effective treatment alternatives. For instance, the World Health Organisation (WHO) reports that 32% of all fatalities worldwide were attributable to CVDs, affecting the lives of 17.9 million individuals worldwide. 85% of fatalities were caused by heart-related conditions and strokes. In addition, it is anticipated that an ageing population with heart disease and diabetes will increase demand for angioplasty catheters. However, it is anticipated that the market will be constrained by angioplasty's high price and post-operative complications.
DRIVERS
Cardiovascular disease prevalence is rising, the elderly population is expanding, and technology is advancing.
An important market driver for angioplasty balloons is the rising prevalence of CVD, including coronary artery disease (CAD), peripheral artery disease (PAD), and hypertension. 18.2 million people worldwide die from cardiovascular disease each year, according to the WHO. A patient passes away from a CVD in the US every 34 seconds, according to a CDC analysis. The market for angioplasty balloons is expanding because these CVDs frequently call for angioplasty to widen or unblock clogged blood vessels. According to the World Health Organisation, by 2030, 1 in 6 people will be older than 60. Age raises the risk of cardiovascular disorders, and the growing number of elderly people will increase the demand for angioplasty. According to research, 84% of CAD fatalities happen to adults over 65. The demand for the angioplasty balloon industry is anticipated to grow as the world's population ages.
RESTRAIN
Low Awareness in Developing Nations.
Lack of expertise will impede market progress in underdeveloped nations. The dearth of skilled medical workers, the high prices of surgical procedures, and the unfavourable reimbursement practises in developing and rising countries will all pose problems for the sector. Additionally, the industry's expansion may be hampered by a rise in product recalls and the clinical hazards or outcomes of surgical operations.
OPPORTUNITY
Rising Incidence of the Target Illnesses.
An increase in the prevalence of the target illnesses is one of the main factors fueling the market's development. 486.6 million people worldwide are affected by cardiovascular illnesses, which result in 8.1 million fatalities, according to the WHO (World Health Organisation). 36% of all fatalities globally are represented by this number. In addition, heart attacks are to blame for 86% of all cardiovascular disease-related mortality. Ample opportunities for industry growth are also anticipated to be provided by growing public awareness of minimally invasive surgical techniques, the success rate of balloon angioplasty, the introduction of novel products, and the rising incidence of coronary and peripheral artery diseases in developing nations.
CHALLENGES
Regulation compliance, pressures on payments and prices, and market competition.
To guarantee safety and effectiveness, the angioplasty balloon market is subject to strict regulatory standards. Manufacturers may find it difficult to meet these regulatory requirements when they change and become more sophisticated. Due to varied reimbursement regulations and pricing discussions, getting favourable reimbursement for angioplasty operations and related equipment can sometimes be difficult. Market accessibility and profitability may be affected by pricing demands coming from healthcare systems and insurance firms. The market for angioplasty balloons is quite cutthroat, with several producers vying for market dominance. Businesses struggle to differentiate their offerings and maintain a competitive advantage in terms of value, cost, and features.
Supply chains that enable the manufacturing and distribution of medical devices, particularly angioplasty balloons, may become disrupted as a result of the war. There may be delays or shortages of certain items if manufacturing facilities or shipping routes are impacted. Economic instability in the Russia-Ukraine conflict might result in inflation, currency volatility, and a decline in buying power in the area. The market for angioplasty balloons may be impacted by this circumstance, which may have an influence on the availability and price of medical equipment. changes in the priorities and resources for healthcare, systems frequently have substantial difficulties during times of war, such as increased demand for emergency medical care and a lack of resources. As a result, money and attention may be diverted to meet urgent medical demands, which might have an impact on the investment in and development of innovative technologies.
IMPACT OF ONGOING RECESSION
Deferred or delayed actions people may experience job loss, lower salaries, or monetary insecurity during an economic crisis. Patients may delay or postpone elective operations, such as angioplasty, if they believe they are unnecessary or are unable to pay for them. This could result in a reduced need for angioplasty balloons. Reimbursement difficulties Healthcare systems may experience financial strains during a recession, which might lead to changes in payment practises and lower reimbursement rates. The capacity of hospitals to invest in expensive equipment like angioplasty balloons or the availability of such operations to patients may be impacted by lower reimbursement for medical procedures, including angioplasty.
By Production
Normal Balloons
Cutting/Scoring
Drug-Eluting
By Application
Coronary Angioplasty
Peripheral Angioplasty
By End-Users
Hospitals
Ambulatory Surgical Centers
Other End Users
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
With a revenue share of 36%, North America leads the world market for angioplasty balloons. In the North American region, 1.5 million angioplasties are carried out annually. The market for angioplasty balloons is driven by rising geriatric and cardiovascular disease rates in the USA.
The angioplasty balloon market in the European area is expanding at the quickest rate. With 3.9 million fatalities per year, cardiovascular diseases (CVD) are the leading cause of mortality in the EU. The market for angioplasty balloons is driven by the exponential increase in occurrences of CVD, rising healthcare costs, and innovations in less invasive surgery.
The major key players are Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG., Becton Dickinson, Biomerics, BIOTRONIK Vertriebs GmbH & Co. KG, Boston Scientific Corporation, Cardinal Health, Cordis (Cardinal Health), CTK biotech, Inc, Hexacath, INFINITY Angioplasty Balloon, JOTEC GmbH, Koninklijke Philips N.V, Medtronic Plc, MicroPort Scientific Corporation, and Nipro Medical Corporation, and others.
Philips endovascular:
The most recent data from the Philips Tack Optimised Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial, which was published in June 2022, demonstrated that the Tack (4F) endovascular system, which has FDA approval, offers patients with critical limb ischemia (CLI) or a severe stage of peripheral arterial disease (PAD) a sustained treatment effect and improves quality of life for up to three years.
BrosMed Medical:
The United States Food and Drug Administration granted 510(k) approval to BrosMed Medical in July 2022 for their Tiche 0.035 PTA Balloon Dilation Catheter.
| Report Attributes | Details |
| Market Size in 2023 | US$ 3.05 Bn |
| Market Size by 2031 | US$ 4.18 Bn |
| CAGR | CAGR of 4.01% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Production (Normal Balloons, Cutting/Scoring, Drug-Eluting) • By Application (Coronary Angioplasty, Peripheral Angioplasty) • By End-Users (Hospitals, Ambulatory Surgical Centers, Other End Users) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG., Becton Dickinson, Biomerics, BIOTRONIK Vertriebs GmbH & Co. KG, Boston Scientific Corporation, Cardinal Health, Cordis (Cardinal Health), CTK biotech, Inc, Hexacath, INFINITY Angioplasty Balloon, JOTEC GmbH, Koninklijke Philips N.V, Medtronic Plc, MicroPort Scientific Corporation, and Nipro Medical Corporation |
| Key Drivers | • Cardiovascular disease prevalence is rising, the elderly population is expanding, and technology is advancing. |
| Market Restraints | • Low Awareness in Developing Nations. |
Ans: The CAGR Growth rate of Angioplasty Balloon Market is approx. CAGR 3.8% over the forecast.
Ans: The projected size of Angioplasty Balloon Market by at USD 2947.13 million in 2022 and is expected to reach USD 3971.71 million by 2030.
Ans: The major key players are Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG., Becton Dickinson, Biomerics, BIOTRONIK Vertriebs GmbH & Co. KG, Boston Scientific Corporation, Cardinal Health, Cordis (Cardinal Health), CTK biotech, Inc, Hexacath, INFINITY Angioplasty Balloon, JOTEC GmbH, Koninklijke Philips N.V, Medtronic Plc, MicroPort Scientific Corporation, and Nipro Medical Corporation, and others.
Ans: The earliest angioplasty balloons were made of flexible PVC (polyvinyl chloride) during the Gruentzigs period. The next generation of balloon technology uses cross-linked polyethylene. The two materials that are most often used in the twenty-first century are nylon and polyethene terephthalate (PET).
Ans: The Product Type, Application, End-user, and Region market segments are the most important ones.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Angioplasty Balloon Market, By Production
8.1 Normal Balloons
8.2 Cutting/Scoring
8.3 Drug-Eluting
9. Angioplasty Balloon Market, By Application
9.1 Coronary Angioplasty
9.2 Peripheral Angioplasty
10. Angioplasty Balloon Market, By End-Users
10.1 Hospitals
10.2 Ambulatory Surgical Centers
10.3 Other End Users
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Angioplasty Balloon Market by country
11.2.2North America Angioplasty Balloon Market by Product
11.2.3 North America Angioplasty Balloon Market by Application
11.2.4 North America Angioplasty Balloon Market by End-Users
11.2.5 USA
11.2.5.1 USA Angioplasty Balloon Market by Product
11.2.5.2 USA Angioplasty Balloon Market by Application
11.2.5.3 USA Angioplasty Balloon Market by End-Users
11.2.6 Canada
11.2.6.1 Canada Angioplasty Balloon Market by Product
11.2.6.2 Canada Angioplasty Balloon Market by Application
11.2.6.3 Canada Angioplasty Balloon Market by End-Users
11.2.7 Mexico
11.2.7.1 Mexico Angioplasty Balloon Market by Product
11.2.7.2 Mexico Angioplasty Balloon Market by Application
11.2.7.3 Mexico Angioplasty Balloon Market by End-Users
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Angioplasty Balloon Market by country
11.3.1.2 Eastern Europe Angioplasty Balloon Market by Product
11.3.1.3 Eastern Europe Angioplasty Balloon Market by Application
11.3.1.4 Eastern Europe Angioplasty Balloon Market by End-Users
11.3.1.5 Poland
11.3.1.5.1 Poland Angioplasty Balloon Market by Product
11.3.1.5.2 Poland Angioplasty Balloon Market by Application
11.3.1.5.3 Poland Angioplasty Balloon Market by End-Users
11.3.1.6 Romania
11.3.1.6.1 Romania Angioplasty Balloon Market by Product
11.3.1.6.2 Romania Angioplasty Balloon Market by Application
11.3.1.6.4 Romania Angioplasty Balloon Market by End-Users
11.3.1.7 Turkey
11.3.1.7.1 Turkey Angioplasty Balloon Market by Product
11.3.1.7.2 Turkey Angioplasty Balloon Market by Application
11.3.1.7.3 Turkey Angioplasty Balloon Market by End-Users
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Angioplasty Balloon Market by Product
11.3.1.8.2 Rest of Eastern Europe Angioplasty Balloon Market by Application
11.3.1.8.3 Rest of Eastern Europe Angioplasty Balloon Market by End-Users
11.3.2 Western Europe
11.3.2.1 Western Europe Angioplasty Balloon Market by Product
11.3.2.2 Western Europe Angioplasty Balloon Market by Application
11.3.2.3 Western Europe Angioplasty Balloon Market by End-Users
11.3.2.4 Germany
11.3.2.4.1 Germany Angioplasty Balloon Market by Product
11.3.2.4.2 Germany Angioplasty Balloon Market by Application
11.3.2.4.3 Germany Angioplasty Balloon Market by End-Users
11.3.2.5 France
11.3.2.5.1 France Angioplasty Balloon Market by Product
11.3.2.5.2 France Angioplasty Balloon Market by Application
11.3.2.5.3 France Angioplasty Balloon Market by End-Users
11.3.2.6 UK
11.3.2.6.1 UK Angioplasty Balloon Market by Product
11.3.2.6.2 UK Angioplasty Balloon Market by Application
11.3.2.6.3 UK Angioplasty Balloon Market by End-Users
11.3.2.7 Italy
11.3.2.7.1 Italy Angioplasty Balloon Market by Product
11.3.2.7.2 Italy Angioplasty Balloon Market by Application
11.3.2.7.3 Italy Angioplasty Balloon Market by End-Users
11.3.2.8 Spain
11.3.2.8.1 Spain Angioplasty Balloon Market by Product
11.3.2.8.2 Spain Angioplasty Balloon Market by Application
11.3.2.8.3 Spain Angioplasty Balloon Market by End-Users
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Angioplasty Balloon Market by Product
11.3.2.9.2 Netherlands Angioplasty Balloon Market by Application
11.3.2.9.3 Netherlands Angioplasty Balloon Market by End-Users
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Angioplasty Balloon Market by Product
11.3.2.10.2 Switzerland Angioplasty Balloon Market by Application
11.3.2.10.3 Switzerland Angioplasty Balloon Market by End-Users
11.3.2.11.1 Austria
11.3.2.11.2 Austria Angioplasty Balloon Market by Product
11.3.2.11.3 Austria Angioplasty Balloon Market by Application
11.3.2.11.4 Austria Angioplasty Balloon Market by End-Users
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Angioplasty Balloon Market by Product
11.3.2.12.2 Rest of Western Europe Angioplasty Balloon Market by Application
11.3.2.12.3 Rest of Western Europe Angioplasty Balloon Market by End-Users
11.4 Asia-Pacific
11.4.1 Asia-Pacific Angioplasty Balloon Market by country
11.4.2 Asia-Pacific Angioplasty Balloon Market by Product
11.4.3 Asia-Pacific Angioplasty Balloon Market by Application
11.4.4 Asia-Pacific Angioplasty Balloon Market by End-Users
11.4.5 China
11.4.5.1 China Angioplasty Balloon Market by Product
11.4.5.2 China Angioplasty Balloon Market by End-Users
11.4.5.3 China Angioplasty Balloon Market by Application
11.4.6 India
11.4.6.1 India Angioplasty Balloon Market by Product
11.4.6.2 India Angioplasty Balloon Market by Application
11.4.6.3 India Angioplasty Balloon Market by End-Users
11.4.7 Japan
11.4.7.1 Japan Angioplasty Balloon Market by Product
11.4.7.2 Japan Angioplasty Balloon Market by Application
11.4.7.3 Japan Angioplasty Balloon Market by End-Users
11.4.8 South Korea
11.4.8.1 South Korea Angioplasty Balloon Market by Product
11.4.8.2 South Korea Angioplasty Balloon Market by Application
11.4.8.3 South Korea Angioplasty Balloon Market by End-Users
11.4.9 Vietnam
11.4.9.1 Vietnam Angioplasty Balloon Market by Product
11.4.9.2 Vietnam Angioplasty Balloon Market by Application
11.4.9.3 Vietnam Angioplasty Balloon Market by End-Users
11.4.10 Singapore
11.4.10.1 Singapore Angioplasty Balloon Market by Product
11.4.10.2 Singapore Angioplasty Balloon Market by Application
11.4.10.3 Singapore Angioplasty Balloon Market by End-Users
11.4.11 Australia
11.4.11.1 Australia Angioplasty Balloon Market by Product
11.4.11.2 Australia Angioplasty Balloon Market by Application
11.4.11.3 Australia Angioplasty Balloon Market by End-Users
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Angioplasty Balloon Market by Product
11.4.12.2 Rest of Asia-Pacific Angioplasty Balloon Market by Application
11.4.12.3 Rest of Asia-Pacific Angioplasty Balloon Market by End-Users
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Angioplasty Balloon Market by country
11.5.1.2 Middle East Angioplasty Balloon Market by Product
11.5.1.3 Middle East Angioplasty Balloon Market by Application
11.5.1.4 Middle East Angioplasty Balloon Market by End-Users
11.5.1.5 UAE
11.5.1.5.1 UAE Angioplasty Balloon Market by Product
11.5.1.5.2 UAE Angioplasty Balloon Market by Application
11.5.1.5.3 UAE Angioplasty Balloon Market by End-Users
11.5.1.6 Egypt
11.5.1.6.1 Egypt Angioplasty Balloon Market by Product
11.5.1.6.2 Egypt Angioplasty Balloon Market by Application
11.5.1.6.3 Egypt Angioplasty Balloon Market by End-Users
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Angioplasty Balloon Market by Product
11.5.1.7.2 Saudi Arabia Angioplasty Balloon Market by Application
11.5.1.7.3 Saudi Arabia Angioplasty Balloon Market by End-Users
11.5.1.8 Qatar
11.5.1.8.1 Qatar Angioplasty Balloon Market by Product
11.5.1.8.2 Qatar Angioplasty Balloon Market by Application
11.5.1.8.3 Qatar Angioplasty Balloon Market by End-Users
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Angioplasty Balloon Market by Product
11.5.1.9.2 Rest of Middle East Angioplasty Balloon Market by Application
11.5.1.9.3 Rest of Middle East Angioplasty Balloon Market by End-Users
11.5.2 Africa
11.5.2.1 Africa Transfusion Diagnostics Market by country
11.5.2.2 Africa Angioplasty Balloon Market by Product
11.5.2.3 Africa Angioplasty Balloon Market by Application
11.5.2.4 Africa Angioplasty Balloon Market by End-Users
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Angioplasty Balloon Market by Product
11.5.2.5.2 Nigeria Angioplasty Balloon Market by Application
11.5.2.5.3 Nigeria Angioplasty Balloon Market by End-Users
11.5.2.6 South Africa
11.5.2.6.1 South Africa Angioplasty Balloon Market by Product
11.5.2.6.2 South Africa Angioplasty Balloon Market by Application
11.5.2.6.3 South Africa Angioplasty Balloon Market by End-Users
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Angioplasty Balloon Market by Product
11.5.2.7.2 Rest of Africa Angioplasty Balloon Market by Application
11.5.2.7.3 Rest of Africa Angioplasty Balloon Market by End-Users
11.6 Latin America
11.6.1 Latin America Angioplasty Balloon Market by country
11.6.2 Latin America Angioplasty Balloon Market by Product
11.6.3 Latin America Angioplasty Balloon Market by Application
11.6.4 Latin America Angioplasty Balloon Market by End-Users
11.6.5 Brazil
11.6.5.1 Brazil America Angioplasty Balloon by Product
11.6.5.2 Brazil America Angioplasty Balloon by Application
11.6.5.3 Brazil America Angioplasty Balloon by End-Users
11.6.6 Argentina
11.6.6.1 Argentina America Angioplasty Balloon by Product
11.6.6.2 Argentina America Angioplasty Balloon by Application
11.6.6.3 Argentina America Angioplasty Balloon by End-Users
11.6.7 Colombia
11.6.7.1 Colombia America Angioplasty Balloon by Product
11.6.7.2 Colombia America Angioplasty Balloon by Application
11.6.7.3 Colombia America Angioplasty Balloon by End-Users
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Angioplasty Balloon by Product
11.6.8.2 Rest of Latin America Angioplasty Balloon by Application
11.6.8.3 Rest of Latin America Angioplasty Balloon by End-Users
12 Company profile
12.1 Abbott Laboratories
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Product/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 AngioDynamics.
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 B. Braun Melsungen AG.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Becton Dickinson
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Biomerics
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 BIOTRONIK Vertriebs GmbH & Co.
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 KG, Boston Scientific Corporation
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Cardinal Health
12.8.2 Financials
12.8.3 Product/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Cordis (Cardinal Health)
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 CTK biotech, Inc.
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Biotechnology Reagents & Kits Market size was estimated USD 596.3 billion in 2022 and is expected to reach USD 1374.1 billion by 2030 at a CAGR of 11.0% during the forecast period of 2023-2030.
The Huntington’s Disease Treatment was estimated at USD 380.3 million in 2022 and is poised to reach at 2045.3 million in 2030 anticipated to expand at a compound annual growth rate approx. CAGR of 23.4% for the forecast period of 2023-2030.
The Type 1 Diabetes Market Size was valued at USD 7.59 billion in 2022 and is expected to reach USD 13.64 billion by 2030, and grow at a CAGR of 7.6% over the forecast period 2023-2030.
The Cystic Fibrosis Market size was valued at US$ 7.13 Billion in 2022 and is estimated to reach US$ 39.59 Billion by 2030 with a growing CAGR of 23.9% Over the Forecast Period 2023-2030.
In 2022, The Sports Medicine Market size amounted to USD 5.22 Billion & is estimated to reach USD 9.66 Billion by 2030 and increase at a compound annual growth rate of 8.0% between 2023 and 2030.
The Smart Pills Market size was estimated USD 0.5 billion in 2022 and is expected to reach USD 1.2 billion by 2030 at a CAGR of 11.6% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
